IDYA - CIK 0001676725
The table below shows IDEAYA Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $157.52M | $298.93M | $114.64M | $130.00M | $400.28M | $183.05M |
| Short-term investments | $513.68M | $487.97M | $555.09M | $562.51M | $519.75M | $518.61M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $696.11M |
| $802.65M |
| $685.60M |
| $707.87M |
| $932.21M |
| $713.18M |
| Property, plant & equipment | $8.63M | $8.17M | $8.82M | $8.87M | $8.23M | $7.12M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.03B | $1.19B | $1.04B | $1.10B | $1.24B | $973.66M |
| Accounts payable | $20.74M | $18.43M | $17.27M | $17.63M | $12.57M | $15.89M |
| Total current liabilities | $64.83M | $64.51M | $55.34M | $50.85M | $40.66M | $40.74M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $93.08M | $93.10M | $81.62M | $76.51M | $59.45M | $42.01M |
| Retained earnings | -$835.08M | -$653.27M | -$772.51M | -$695.02M | -$492.53M | -$440.71M |
| Total equity | $937.27M | $1.09B | $959.65M | $1.02B | $1.18B | $931.66M |